Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Type I collagen deletion in αSMA+ myofibroblasts augments immune suppression and accelerates progression of pancreatic cancer
Yang Chen, Jiha Kim, Sujuan Yang, et al.
Cancer Cell (2021) Vol. 39, Iss. 4, pp. 548-565.e6
Open Access | Times Cited: 398

Showing 1-25 of 398 citing articles:

Clinical and therapeutic relevance of cancer-associated fibroblasts
Yang Chen, Kathleen M. McAndrews, Raghu Kalluri
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 792-804
Open Access | Times Cited: 757
Pancreatic cancer: Advances and challenges
Christopher J. Halbrook, Costas A. Lyssiotis, Marina Pasca di Magliano, et al.
Cell (2023) Vol. 186, Iss. 8, pp. 1729-1754
Open Access | Times Cited: 563
Dynamic EMT: a multi‐tool for tumor progression
Simone Brabletz, Harald Schuhwerk, Thomas Brabletz, et al.
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 506
Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments
Zhennan Yuan, Yingpu Li, Sifan Zhang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 368
The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
Christiana M. Neophytou, Myrofora Panagi, Triantafyllos Stylianopoulos, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2053-2053
Open Access | Times Cited: 311
Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Xiujie Sun, Bogang Wu, Huai-Chin Chiang, et al.
Nature (2021) Vol. 599, Iss. 7886, pp. 673-678
Open Access | Times Cited: 256
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis
Aveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Nature (2022) Vol. 610, Iss. 7931, pp. 356-365
Open Access | Times Cited: 198
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 177
Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms
Haichuan Hu, Zofia Piotrowska, Patricia J. Hare, et al.
Cancer Cell (2021) Vol. 39, Iss. 11, pp. 1531-1547.e10
Open Access | Times Cited: 175
Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer
Kathleen M. McAndrews, Yang Chen, J. Kebbeh Darpolor, et al.
Cancer Discovery (2022) Vol. 12, Iss. 6, pp. 1580-1597
Open Access | Times Cited: 174
Oncogenic collagen I homotrimers from cancer cells bind to α3β1 integrin and impact tumor microbiome and immunity to promote pancreatic cancer
Yang Chen, Sujuan Yang, Jena Tavormina, et al.
Cancer Cell (2022) Vol. 40, Iss. 8, pp. 818-834.e9
Open Access | Times Cited: 162
Therapeutic targeting of tumour myeloid cells
Simon T. Barry, Dmitry I. Gabrilovich, Owen J. Sansom, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 4, pp. 216-237
Closed Access | Times Cited: 152
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
Xinglong Geng, Hongze Chen, Liang Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
Immune Modulatory Properties of Collagen in Cancer
Anne Mette Askehøj Rømer, Marie‐Louise Thorseth, Daniel H. Madsen
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 138
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Cancer-Associated Fibroblasts in Inflammation and Antitumor Immunity
Kilian B. Kennel, Müge Bozlar, Adalbert F. De Valk, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 6, pp. 1009-1016
Open Access | Times Cited: 130
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
Michael Papanicolaou, Amelia L. Parker, Michelle Yam, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 129
Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?
Ismahane Belhabib, Sonia Zaghdoudi, Claire Lac, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3466-3466
Open Access | Times Cited: 105
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 102
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 96
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Lena Cords, Stefanie Engler, Martina Haberecker, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 396-412.e5
Open Access | Times Cited: 94
B cells in the tumor microenvironment: Multi-faceted organizers, regulators, and effectors of anti-tumor immunity
Céline M. Laumont, Brad H. Nelson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 466-489
Open Access | Times Cited: 92
Cholangiocarcinoma — novel biological insights and therapeutic strategies
Sumera I. Ilyas, Silvia Affò, Lipika Goyal, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 470-486
Open Access | Times Cited: 92
Page 1 - Next Page

Scroll to top